Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for VNDA

Stock Name	Vanda Pharmaceuticals Inc
Ticker	VNDA(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US9216591084
LEI	529900AY8VOOQBKJ0O70

Show aggregate VNDA holdings

News associated with VNDA

XTX Topco Ltd Has $318,000 Holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA): XTX Topco Ltd grew its holdings in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 378.3% during the first quarter, HoldingsChannel.com reports. The firm owned 69,329 shares of the biopharmaceutical company’s stock after acquiring an additional 54,833 shares during the quarter. XTX Topco Ltd’s holdings in Vanda Pharmaceuticals were worth $318,000 as of […] - 2025-08-11 05:34:58
Vanda (VNDA) Q2 Revenue Rises 4%: Key PointsNet loss (GAAP) widened sharply due to increased spending in Q2 2025, with GAAP EPS was ($0.46) for Q2 2025. - 2025-08-01 05:18:57
GSA Capital Partners LLP Raises Position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA): GSA Capital Partners LLP increased its stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 88.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 260,215 shares of the biopharmaceutical company’s stock after acquiring an additional 121,797 shares during the […] - 2025-07-31 04:29:06
Public Employees Retirement System of Ohio Has $426,000 Stock Position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA): Public Employees Retirement System of Ohio reduced its position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 16.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 89,032 shares of the biopharmaceutical company’s stock after selling 17,200 shares during the period. Public Employees Retirement System of Ohio […] - 2025-06-05 05:23:00
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Shares Acquired by Two Sigma Advisers LP: Two Sigma Advisers LP raised its stake in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 11.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 156,300 shares of the biopharmaceutical company’s stock after acquiring an additional 15,700 shares […] - 2025-06-03 04:56:54
Short Interest in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Expands By 21.4%: Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) saw a significant increase in short interest in April. As of April 15th, there was short interest totalling 4,880,000 shares, an increase of 21.4% from the March 31st total of 4,020,000 shares. Based on an average daily volume of 663,100 shares, the days-to-cover ratio is currently 7.4 […] - 2025-05-05 02:35:06
XTX Topco Ltd Makes New Investment in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA): XTX Topco Ltd purchased a new position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) in the 4th quarter, Holdings Channel reports. The institutional investor purchased 14,496 shares of the biopharmaceutical company’s stock, valued at approximately $69,000. A number of other hedge funds also recently modified their holdings of VNDA. Geode Capital Management LLC boosted […] - 2025-05-01 05:28:58
Geode Capital Management LLC Buys 24,483 Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA): Geode Capital Management LLC raised its position in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 1.7% in the fourth quarter, HoldingsChannel reports. The fund owned 1,450,310 shares of the biopharmaceutical company’s stock after acquiring an additional 24,483 shares during the period. Geode Capital Management LLC’s holdings in Vanda Pharmaceuticals were worth $6,949,000 […] - 2025-04-25 04:26:50
Vanguard Group Inc. Has $16.80 Million Position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA): Vanguard Group Inc. lessened its holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 3.4% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 3,506,287 shares of the biopharmaceutical company’s stock after selling 125,002 shares during the period. Vanguard Group Inc. owned approximately 0.06% of Vanda Pharmaceuticals worth $16,795,000 as of its most […] - 2025-04-17 04:25:09
ExodusPoint Capital Management LP Decreases Stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA): ExodusPoint Capital Management LP trimmed its holdings in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 74.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 31,506 shares of the biopharmaceutical company’s stock after selling 94,144 shares during the quarter. ExodusPoint […] - 2025-04-15 04:39:18
American Century Companies Inc. Raises Stock Holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA): American Century Companies Inc. increased its holdings in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 2.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 300,276 shares of the biopharmaceutical company’s stock after acquiring an additional 6,079 shares during the […] - 2025-04-10 04:28:52
135,400 Shares in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Bought by KLP Kapitalforvaltning AS: KLP Kapitalforvaltning AS bought a new stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 135,400 shares of the biopharmaceutical company’s stock, valued at approximately $649,000. KLP Kapitalforvaltning AS owned […] - 2025-04-02 05:16:59
Bank of New York Mellon Corp Cuts Holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA): Bank of New York Mellon Corp lessened its stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 14.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 175,017 shares of the biopharmaceutical company’s stock after selling 30,260 shares during the quarter. Bank of New York Mellon Corp’s […] - 2025-03-26 05:12:48
Reviewing Vanda Pharmaceuticals (NASDAQ:VNDA) & Rapport Therapeutics (NASDAQ:RAPP): Vanda Pharmaceuticals (NASDAQ:VNDA – Get Free Report) and Rapport Therapeutics (NASDAQ:RAPP – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations. Analyst Ratings This is a breakdown of […] - 2025-03-25 03:36:46
Vanda Pharmaceuticals (NASDAQ:VNDA) Given New $20.00 Price Target at HC Wainwright: Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) had its price target upped by HC Wainwright from $18.00 to $20.00 in a research note issued to investors on Tuesday morning,Benzinga reports. HC Wainwright currently has a buy rating on the biopharmaceutical company’s stock. Separately, StockNews.com initiated coverage on Vanda Pharmaceuticals in a report on Wednesday, February 5th. […] - 2025-02-19 04:56:52
Vanda Pharmaceuticals (NASDAQ:VNDA) Now Covered by StockNews.com: Analysts at StockNews.com began coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Get Free Report) in a research report issued on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a “buy” rating and issued a $18.00 price objective on shares of Vanda Pharmaceuticals in a research report […] - 2025-02-07 04:20:53
Comparing Vanda Pharmaceuticals (NASDAQ:VNDA) & Cyclerion Therapeutics (NASDAQ:CYCN): Vanda Pharmaceuticals (NASDAQ:VNDA – Get Free Report) and Cyclerion Therapeutics (NASDAQ:CYCN – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends. Profitability This table compares Vanda Pharmaceuticals and […] - 2025-02-05 04:26:43

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) VNDA holdings

Date	Number of VNDA Shares Held	Base Market Value of VNDA Shares	Local Market Value of VNDA Shares	Change in VNDA Shares Held	Change in VNDA Base Value	Current Price per VNDA Share Held	Previous Price per VNDA Share Held
2025-12-03 (Wednesday)	44,667	USD 235,395	USD 235,395	0	USD 15,633	USD 5.27	USD 4.92001
2025-12-02 (Tuesday)	44,667	USD 219,762	USD 219,762	1,665	USD 3,892	USD 4.92001	USD 5.02
2025-12-01 (Monday)	43,002	USD 215,870	USD 215,870	0	USD -14,621	USD 5.02	USD 5.36001
2025-11-28 (Friday)	43,002	USD 230,491	USD 230,491	110	USD 3,163	USD 5.36001	USD 5.30001
2025-11-27 (Thursday)	42,892	USD 227,328	USD 227,328	0	USD 0	USD 5.30001	USD 5.30001
2025-11-26 (Wednesday)	42,892	USD 227,328	USD 227,328	333	USD 14,533	USD 5.30001	USD 5
2025-11-25 (Tuesday)	42,559	USD 212,795	USD 212,795	555	USD 7,395	USD 5	USD 4.89001
2025-11-24 (Monday)	42,004	USD 205,400	USD 205,400	111	USD 4,314	USD 4.89001	USD 4.79999
2025-11-21 (Friday)	41,893	USD 201,086	USD 201,086	0	USD -1,676	USD 4.79999	USD 4.84
2025-11-20 (Thursday)	41,893	USD 202,762	USD 202,762	-436	USD -14,809	USD 4.84	USD 5.14
2025-11-19 (Wednesday)	42,329	USD 217,571	USD 217,571	763	USD -4,807	USD 5.14	USD 5.35
2025-11-18 (Tuesday)	41,566	USD 222,378	USD 222,378	0	USD 39,488	USD 5.35	USD 4.39999
2025-11-17 (Monday)	41,566	USD 182,890	USD 182,890	220	USD 3,035	USD 4.39999	USD 4.35

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of VNDA by Blackrock for IE00BDZVHG35

Show aggregate share trades of VNDA

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 BUY 1,665 4.920* 4.67
2025-11-28 BUY 110 5.360* 4.67
2025-11-26 BUY 333 5.300* 4.66
2025-11-25 BUY 555 5.000* 4.66
2025-11-24 BUY 111 4.890* 4.66
2025-11-20 SELL -436 4.840* 4.66 Profit of 2,031 on sale
2025-11-19 BUY 763 5.140* 4.66
2025-11-17 BUY 220 4.400* 4.65
2025-11-14 BUY 110 4.350* 4.66
2025-11-12 BUY 109 4.410* 4.66
2025-11-10 BUY 109 4.420* 4.66
2025-11-06 BUY 109 4.410* 4.66
2025-11-04 BUY 109 4.350* 4.67
2025-10-31 BUY 545 4.510 4.280 4.303 USD 2,345 4.67
2025-10-29 BUY 218 5.410 5.630 5.608 USD 1,223 4.67
2025-10-22 SELL -432 5.340 5.380 5.376 USD -2,322 4.64 Loss of -316 on sale
2025-10-20 BUY 214 5.330 5.450 5.438 USD 1,164 4.64
2025-10-17 BUY 538 5.270 5.310 5.306 USD 2,855 4.63
2025-10-15 BUY 848 5.380 5.400 5.398 USD 4,578 4.63
2025-10-03 BUY 763 5.430 5.480 5.475 USD 4,177 4.62
2025-10-02 BUY 109 5.160 5.220 5.214 USD 568 4.62
2025-09-30 BUY 218 4.990 5.000 4.999 USD 1,090 4.61
2025-09-26 BUY 220 5.100 5.120 5.118 USD 1,126 4.61
2025-09-25 BUY 220 4.830 4.920 4.911 USD 1,080 4.61
2025-09-18 BUY 110 4.520 4.540 4.538 USD 499 4.61
2025-09-17 BUY 330 4.390 4.500 4.489 USD 1,481 4.61
2025-09-11 SELL -110 4.600 4.600 4.600 USD -506 4.61 Profit of 1 on sale
2025-09-10 BUY 220 4.480 4.640 4.624 USD 1,017 4.61
2025-07-17 SELL -214 4.860 4.890 4.887 USD -1,046 4.61 Loss of -60 on sale
2025-07-11 SELL -872 4.740 5.000 4.974 USD -4,337 4.60 Loss of -325 on sale
2025-07-02 BUY 5,995 4.890 4.900 4.899 USD 29,370 4.59
2025-06-25 BUY 216 4.610 4.640 4.637 USD 1,002 4.59
2025-06-11 BUY 218 4.580 4.720 4.706 USD 1,026 4.59
2025-06-10 BUY 218 4.660 4.700 4.696 USD 1,024 4.59
2025-06-04 SELL -109 4.440 4.460 4.458 USD -486 4.59 Profit of 15 on sale
2025-04-23 BUY 109 4.330 4.490 4.474 USD 488 4.69
2025-04-10 SELL -872 4.080 4.100 4.098 USD -3,573 4.73 Profit of 548 on sale
2025-04-08 SELL -109 4.140 4.300 4.284 USD -467 4.74 Profit of 50 on sale
2025-04-07 SELL -109 4.190 4.260 4.253 USD -464 4.75 Profit of 54 on sale
2025-04-04 SELL -550 4.140 4.330 4.311 USD -2,371 4.75 Profit of 243 on sale
2025-04-01 BUY 436 4.500 4.640 4.626 USD 2,017 4.76
2025-03-31 SELL -327 4.590 4.730 4.716 USD -1,542 4.76 Profit of 15 on sale
2025-03-21 BUY 4,845 4.770 4.960 4.941 USD 23,939 4.76
2025-03-14 SELL -1,488 4.980 5.070 5.061 USD -7,531 4.75 Loss of -466 on sale
2025-03-07 SELL -186 4.850 5.060 5.039 USD -937 4.74 Loss of -56 on sale
2025-03-04 SELL -93 4.810 4.830 4.828 USD -449 4.73 Loss of -9 on sale
2025-02-25 BUY 186 4.460 4.500 4.496 USD 836 4.73
2025-02-19 SELL -93 4.550 4.640 4.631 USD -431 4.75 Profit of 11 on sale
2025-02-13 BUY 279 4.700 4.800 4.790 USD 1,336 4.77
2025-02-12 BUY 93 4.750 4.780 4.777 USD 444 4.77
2025-02-11 BUY 368 4.720 4.750 4.747 USD 1,747 4.77
2024-12-30 SELL -5,840 4.780 4.900 4.888 USD -28,546 4.88 Loss of -68 on sale
2024-11-18 SELL -1,650 4.980 5.070 5.061 USD -8,351 4.79 Loss of -441 on sale
2024-11-08 SELL -110 5.190 5.230 5.226 USD -575 4.72 Loss of -55 on sale
2024-10-21 SELL -111 4.730 4.930 4.910 USD -545 0.00 Loss of -545 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	1,665			4.920*		4.67
2025-11-28	BUY	110			5.360*		4.67
2025-11-26	BUY	333			5.300*		4.66
2025-11-25	BUY	555			5.000*		4.66
2025-11-24	BUY	111			4.890*		4.66
2025-11-20	SELL	-436			4.840*		4.66 Profit of 2,031 on sale
2025-11-19	BUY	763			5.140*		4.66
2025-11-17	BUY	220			4.400*		4.65
2025-11-14	BUY	110			4.350*		4.66
2025-11-12	BUY	109			4.410*		4.66
2025-11-10	BUY	109			4.420*		4.66
2025-11-06	BUY	109			4.410*		4.66
2025-11-04	BUY	109			4.350*		4.67
2025-10-31	BUY	545	4.510	4.280	4.303	USD 2,345	4.67
2025-10-29	BUY	218	5.410	5.630	5.608	USD 1,223	4.67
2025-10-22	SELL	-432	5.340	5.380	5.376	USD -2,322	4.64 Loss of -316 on sale
2025-10-20	BUY	214	5.330	5.450	5.438	USD 1,164	4.64
2025-10-17	BUY	538	5.270	5.310	5.306	USD 2,855	4.63
2025-10-15	BUY	848	5.380	5.400	5.398	USD 4,578	4.63
2025-10-03	BUY	763	5.430	5.480	5.475	USD 4,177	4.62
2025-10-02	BUY	109	5.160	5.220	5.214	USD 568	4.62
2025-09-30	BUY	218	4.990	5.000	4.999	USD 1,090	4.61
2025-09-26	BUY	220	5.100	5.120	5.118	USD 1,126	4.61
2025-09-25	BUY	220	4.830	4.920	4.911	USD 1,080	4.61
2025-09-18	BUY	110	4.520	4.540	4.538	USD 499	4.61
2025-09-17	BUY	330	4.390	4.500	4.489	USD 1,481	4.61
2025-09-11	SELL	-110	4.600	4.600	4.600	USD -506	4.61 Profit of 1 on sale
2025-09-10	BUY	220	4.480	4.640	4.624	USD 1,017	4.61
2025-07-17	SELL	-214	4.860	4.890	4.887	USD -1,046	4.61 Loss of -60 on sale
2025-07-11	SELL	-872	4.740	5.000	4.974	USD -4,337	4.60 Loss of -325 on sale
2025-07-02	BUY	5,995	4.890	4.900	4.899	USD 29,370	4.59
2025-06-25	BUY	216	4.610	4.640	4.637	USD 1,002	4.59
2025-06-11	BUY	218	4.580	4.720	4.706	USD 1,026	4.59
2025-06-10	BUY	218	4.660	4.700	4.696	USD 1,024	4.59
2025-06-04	SELL	-109	4.440	4.460	4.458	USD -486	4.59 Profit of 15 on sale
2025-04-23	BUY	109	4.330	4.490	4.474	USD 488	4.69
2025-04-10	SELL	-872	4.080	4.100	4.098	USD -3,573	4.73 Profit of 548 on sale
2025-04-08	SELL	-109	4.140	4.300	4.284	USD -467	4.74 Profit of 50 on sale
2025-04-07	SELL	-109	4.190	4.260	4.253	USD -464	4.75 Profit of 54 on sale
2025-04-04	SELL	-550	4.140	4.330	4.311	USD -2,371	4.75 Profit of 243 on sale
2025-04-01	BUY	436	4.500	4.640	4.626	USD 2,017	4.76
2025-03-31	SELL	-327	4.590	4.730	4.716	USD -1,542	4.76 Profit of 15 on sale
2025-03-21	BUY	4,845	4.770	4.960	4.941	USD 23,939	4.76
2025-03-14	SELL	-1,488	4.980	5.070	5.061	USD -7,531	4.75 Loss of -466 on sale
2025-03-07	SELL	-186	4.850	5.060	5.039	USD -937	4.74 Loss of -56 on sale
2025-03-04	SELL	-93	4.810	4.830	4.828	USD -449	4.73 Loss of -9 on sale
2025-02-25	BUY	186	4.460	4.500	4.496	USD 836	4.73
2025-02-19	SELL	-93	4.550	4.640	4.631	USD -431	4.75 Profit of 11 on sale
2025-02-13	BUY	279	4.700	4.800	4.790	USD 1,336	4.77
2025-02-12	BUY	93	4.750	4.780	4.777	USD 444	4.77
2025-02-11	BUY	368	4.720	4.750	4.747	USD 1,747	4.77
2024-12-30	SELL	-5,840	4.780	4.900	4.888	USD -28,546	4.88 Loss of -68 on sale
2024-11-18	SELL	-1,650	4.980	5.070	5.061	USD -8,351	4.79 Loss of -441 on sale
2024-11-08	SELL	-110	5.190	5.230	5.226	USD -575	4.72 Loss of -55 on sale
2024-10-21	SELL	-111	4.730	4.930	4.910	USD -545	0.00 Loss of -545 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VNDA

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	42,774	2,453	131,244	32.6%
2025-09-18	25,487	0	103,697	24.6%
2025-09-17	42,313	0	99,513	42.5%
2025-09-16	16,592	0	110,453	15.0%
2025-09-15	49,998	4,027	122,733	40.7%
2025-09-12	55,842	0	160,488	34.8%
2025-09-11	42,447	0	110,256	38.5%
2025-09-10	25,113	1,000	115,790	21.7%
2025-09-09	31,129	446	70,773	44.0%
2025-09-08	28,194	0	68,400	41.2%
2025-09-05	27,068	0	125,697	21.5%
2025-09-04	113,956	17,115	231,507	49.2%
2025-09-03	54,340	0	112,436	48.3%
2025-09-02	52,592	4,793	241,174	21.8%
2025-08-29	26,190	0	81,421	32.2%
2025-08-28	45,898	0	150,189	30.6%
2025-08-27	19,368	5,600	96,935	20.0%
2025-08-26	52,199	200	124,704	41.9%
2025-08-25	40,000	199	161,310	24.8%
2025-08-22	45,003	0	127,801	35.2%
2025-08-21	57,678	0	170,952	33.7%
2025-08-20	22,347	0	105,692	21.1%
2025-08-19	55,399	203	176,148	31.5%
2025-08-18	188,374	11,471	480,631	39.2%
2025-08-15	47,358	0	111,575	42.4%
2025-08-14	56,845	7	138,850	40.9%
2025-08-13	47,990	0	178,443	26.9%
2025-08-12	83,180	8,700	251,642	33.1%
2025-08-11	58,803	0	148,163	39.7%
2025-08-08	57,309	0	117,859	48.6%
2025-08-07	87,919	2,763	143,066	61.5%
2025-08-06	139,442	3,417	252,623	55.2%
2025-08-05	71,928	0	173,007	41.6%
2025-08-04	102,812	118	269,247	38.2%
2025-08-01	168,331	9,932	356,470	47.2%
2025-07-31	366,630	25,169	758,404	48.3%
2025-07-30	101,622	19,723	407,514	24.9%
2025-07-29	54,833	0	160,273	34.2%
2025-07-28	35,669	8,395	106,256	33.6%
2025-07-25	90,519	4	154,637	58.5%
2025-07-24	49,307	648	146,927	33.6%
2025-07-23	69,319	0	165,089	42.0%
2025-07-22	42,768	8,190	106,058	40.3%
2025-07-21	51,559	500	211,909	24.3%
2025-07-18	52,510	10	131,904	39.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE